E. Stevens-Linders

Acquired mutations in TET2 are common in myelodysplastic syndromes

A. Hagemeijer, R. Kuiper, J. Jansen, 2009, Nature Genetics.

Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial

R. Willemze, D. Cilloni, G. Saglio, 2014, Annals of Hematology.

Acquired skewing of Lyonization remains stable for a prolonged period in healthy blood donors

E. Stevens-Linders, T. Witte, J. Jansen, 2002, Leukemia.

Genetic defects in PRC2 components other than EZH2 are not common in myeloid malignancies.

T. Haferlach, S. Schnittger, R. Kuiper, 2012, Blood.

TET2 mutations in childhood leukemia

C. Zwaan, J. Jansen, E. Sonneveld, 2011, Leukemia.